Market Overview:
The global drug coated endotracheal tube market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory diseases, rising geriatric population, and technological advancements in drug coated endotracheal tubes. Based on type, the global drug coated endotracheal tube market can be segmented into oral or nasal tubes, cuffed or uncuffed tubes, preformed tubes, reinforced tubes, and double-lumen endobronchial tubes. The oral or nasal tube segment is expected to account for the largest share of the global market in 2018 owing to its ease of use and low cost as compared to other types of drug coated endotracheal tubes. Based on application, hospitals are expected to account for the largest share of the global market in 2018 followed by clinics. However, clinics are projected to witness higher growth during the forecast period due from increasing demand for outpatient procedures.
Product Definition:
A drug-coated endotracheal tube is a device that is inserted through the mouth or nose and passed down the throat into the airways to help a person breathe. The tube has a small,drug-coated balloon on its tip that is inflated once it is in place to hold it in place and release medication directly into the airways.
Oral or Nasal Tube:
Oral or nasal tube is a flexible, hollow plastic device that is inserted into the nose through the mouth and down into the trachea (windpipe). It's role in anesthesia consists of two major functions, namely as an airway clearance device and as an emergency airway. The size of oral or nasal tubes varies according to their use; they are available in sizes ranging from 3ml to 300ml capacity.
Cuffed or Uncuffed Tube:
Cuffed or Uncuffed tube refers to the type of endotracheal tube used in mechanical ventilation. The cuffed endotracheal tube is a preferred choice by healthcare professionals as it reduces the risk of aspiration and protects against gastric contents entering into the lungs.
The global uncuffed endotracheal tube market was valued at USD 536 million in 2013.
Application Insights:
Based on application, the global drug coated endotracheal tubes market is segmented into hospitals, clinics and others. Hospitals held the largest share in 2017 owing to factors such as increasing healthcare spending and government initiatives to promote hospitalization. For instance, Germany¢â‚¬â„¢s ¢â‚¬Å“Gesundheitsfonds¢â‚¬ or Health Funds are intended to cover all medical costs if a patient requires a hospital stay of more than three days. These initiatives are expected to increase the utilization of ECETs in hospitals over the forecast period.
ECETs have high preference for use in emergency treatment due largely to their ability provide direct ventilation without any intervention by an interventionalist during times when intubation may be difficult or hazardous due its size.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position during the forecast period. The presence of a large number of manufacturers coupled with increasing demand for advanced products in emerging economies such as China, India, and Japan are some factors contributing to the growth of this region. Moreover, rising awareness regarding chronic respiratory diseases among patients and healthcare professionals is also expected to drive growth over the forecast period.
Europe accounted for more than 25% share in 2017 owing to high prevalence of COPD coupled with growing geriatric population base. In addition, favorable reimbursement policies pertaining endotracheal tubes are other factors driving regional market growth over the forecast period.
Growth Factors:
- Increasing incidence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for drug coated endotracheal tubes as they offer better treatment outcomes.
- Technological advancements: Drug coated endotracheal tubes are being increasingly used due to technological advancements such as the use of low-dose drugs, which helps in reducing side effects.
- Rising geriatric population: The geriatric population is more susceptible to respiratory diseases and thus, there is a growing demand for drug coated endotracheal tubes for their treatment.
- Growing awareness about benefits of drug coated endotracheal tubes: There is a growing awareness among healthcare professionals about the benefits of using drug coated endotracheal tubes, which is likely to boost market growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Coated Endotracheal Tube Market Research Report
By Type
Oral or Nasal Tube, Cuffed or Uncuffed Tube, Preformed Tube, Reinforced Tube, Double-Lumen Endobronchial Tube
By Application
Hospitals, Clinic, Others
By Companies
Teleflex, C. R. Bard, AirWay Technologies, Allvivo Vascular, BRIO DEVICE, Medtronic, Smiths, Becton Dickinson, Enox Biopharma, Merit Medical Systems, Teleflex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Drug Coated Endotracheal Tube Market Report Segments:
The global Drug Coated Endotracheal Tube market is segmented on the basis of:
Types
Oral or Nasal Tube, Cuffed or Uncuffed Tube, Preformed Tube, Reinforced Tube, Double-Lumen Endobronchial Tube
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teleflex
- C. R. Bard
- AirWay Technologies
- Allvivo Vascular
- BRIO DEVICE
- Medtronic
- Smiths
- Becton Dickinson
- Enox Biopharma
- Merit Medical Systems
- Teleflex
Highlights of The Drug Coated Endotracheal Tube Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral or Nasal Tube
- Cuffed or Uncuffed Tube
- Preformed Tube
- Reinforced Tube
- Double-Lumen Endobronchial Tube
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Coated Endotracheal Tube Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A drug-coated endotracheal tube is a type of breathing tube that helps protect the patient's lungs from infection. The coating helps to prevent bacteria and other particles from entering the patient's lungs.
Some of the major companies in the drug coated endotracheal tube market are Teleflex, C. R. Bard, AirWay Technologies, Allvivo Vascular, BRIO DEVICE, Medtronic, Smiths, Becton Dickinson, Enox Biopharma, Merit Medical Systems, Teleflex.
The drug coated endotracheal tube market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Coated Endotracheal Tube Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Coated Endotracheal Tube Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Coated Endotracheal Tube Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Coated Endotracheal Tube Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Coated Endotracheal Tube Market Size & Forecast, 2020-2028
4.5.1 Drug Coated Endotracheal Tube Market Size and Y-o-Y Growth
4.5.2 Drug Coated Endotracheal Tube Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral or Nasal Tube
5.2.2 Cuffed or Uncuffed Tube
5.2.3 Preformed Tube
5.2.4 Reinforced Tube
5.2.5 Double-Lumen Endobronchial Tube
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Coated Endotracheal Tube Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Coated Endotracheal Tube Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral or Nasal Tube
9.6.2 Cuffed or Uncuffed Tube
9.6.3 Preformed Tube
9.6.4 Reinforced Tube
9.6.5 Double-Lumen Endobronchial Tube
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral or Nasal Tube
10.6.2 Cuffed or Uncuffed Tube
10.6.3 Preformed Tube
10.6.4 Reinforced Tube
10.6.5 Double-Lumen Endobronchial Tube
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral or Nasal Tube
11.6.2 Cuffed or Uncuffed Tube
11.6.3 Preformed Tube
11.6.4 Reinforced Tube
11.6.5 Double-Lumen Endobronchial Tube
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral or Nasal Tube
12.6.2 Cuffed or Uncuffed Tube
12.6.3 Preformed Tube
12.6.4 Reinforced Tube
12.6.5 Double-Lumen Endobronchial Tube
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral or Nasal Tube
13.6.2 Cuffed or Uncuffed Tube
13.6.3 Preformed Tube
13.6.4 Reinforced Tube
13.6.5 Double-Lumen Endobronchial Tube
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Coated Endotracheal Tube Market: Competitive Dashboard
14.2 Global Drug Coated Endotracheal Tube Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teleflex
14.3.2 C. R. Bard
14.3.3 AirWay Technologies
14.3.4 Allvivo Vascular
14.3.5 BRIO DEVICE
14.3.6 Medtronic
14.3.7 Smiths
14.3.8 Becton Dickinson
14.3.9 Enox Biopharma
14.3.10 Merit Medical Systems
14.3.11 Teleflex
